Eric Suda
About Eric Suda
Eric Suda serves as the Director and Head of MS&T at Precision BioSciences, Inc., bringing extensive experience in biochemistry and biotechnology. He has held various roles in prominent companies such as Pfizer, Novartis Vaccines, and KBI Biopharma throughout his career.
Current Role at Precision BioSciences
Eric Suda serves as the Director and Head of MS&T at Precision BioSciences, Inc. since 2022. His role involves overseeing the manufacturing science and technology functions within the organization. He is based in Durham, North Carolina, where he contributes to the company's mission in the biotechnology sector.
Professional Experience in Biopharmaceuticals
Prior to his current position, Eric Suda held various roles in the biopharmaceutical industry. He worked at KBI Biopharma as Associate Director of MS&T for 11 months in 2021 and previously served as Senior Manager of MS&T, Downstream from 2019 to 2021. His experience also includes positions at Novartis Vaccines, Novo Nordisk, Pfizer, and GlaxoSmithKline, where he contributed as a scientist and process engineer.
Educational Background in Biochemistry
Eric Suda earned a Master of Science in Biochemistry and Biotechnology from the University of Missouri-Saint Louis, completing his studies from 2006 to 2009. He also holds a Bachelor of Science in Biochemistry from the University of Missouri-Columbia, where he studied from 1999 to 2004. His educational background provides a strong foundation for his work in the biopharmaceutical field.
Career Progression in the Biotechnology Sector
Eric Suda's career in the biotechnology sector spans multiple companies and roles. He began his career at Pfizer as a scientist from 2004 to 2009, followed by a position at GlaxoSmithKline from 2009 to 2011. He then transitioned to Novartis Vaccines and later to KBI Biopharma, where he advanced through various positions, including Senior Scientist and Work Package Owner - Process Engineer at Novo Nordisk.